Regardless..PFE is the worst big pharma stock, and its stock price behavior is very erratic. You will not see $21 soon. Lucky if it holds onto $17 area thru Dec 2009. It went down again today for no reason.
Hassan has been gone a long time and Kindler has to take the responsibility now. GE is in a BAD shape because of a very deep exposure of GE's banking unit in the declining commercial real estate market and had to cut the dividend, and had NO choice. PFE on the other hand is awash in cash flow and didn't have to CUT the dividend this DRASTICALLY. The contaminated batch of vaccine was from WYE and it was a big mistake for PFE to throw away $68B to acquire the run -of-the-mill type drug company. On the other hand MRK-SGP merger is very well received and MRK is forcasting much better things to come.
PFE is going to have many problems in incorporating WYE. Instaed, they could had bought a couple of smaller biotech companies for far less, but Kindler has a short vision. PFE's last 2 years stock performance is nothing to write home about.. down down from $22 to $17. If you had bought 10,000 shares then, you would be minus $50,000 today.